Pediatric Sarcoma
Vincristine, ifosfamide, and doxorubicin treated pediatric sarcomas
Published in Vaccine Weekly, September 7th, 2005
In a recent report published in the Journal of Clinical Oncology, researchers in Canada conducted a study "to describe the response rate and survival of children and adolescents with unresected or metastatic NRSTS treated with vincristine, ifosfamide, and doxorubicin."
"Between September 1996 and June 2000, 39 eligible patients received vincristine (1.5 mg/m2 weekly for 13 doses), ifosfamide (3 g/m2 daily for 3 days every 3 weeks for 7 cycles), doxorubicin (30...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-09-07)
More Articles from Vaccine Weekly
- Cancer Vaccine
Carbohydrate vaccines as immunotherapy for cancer reviewed - Colon Cancer Vaccine
Oral vaccine induces immune responses against carcinoembryonic antigen - Lassa Fever Vaccine
New vaccine for prevention of Lassa fever developed - Prostate Cancer Vaccine
Antibody to prostate-specific membrane antigen used for cancer therapy - Vaccine Vector
Interference with IL-1-signaling reduces toxicity of adenovirus vectors - Adolescent Health
Challenges to vaccinating adolescents outlined - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
